Announcements Trials
Browse Landscape

Phase

Phase EARLY_PHASE1 1

Status

Unknown 1Active not recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Dermatologic 1

Conditions

Carcinoma, Non-Small-Cell Lung 4Colorectal Neoplasms 3Skin Neoplasms 2Melanoma 2Esophageal Neoplasms 2Carcinoma, Hepatocellular 2Urologic Neoplasms 1Urologic Diseases 1Urinary Bladder Neoplasms 1Urinary Bladder Diseases 1Turcot syndrome 1Solid Tumors 1Solid Tumor, Adult 1Rectal Neoplasms 1Radiation Pneumonitis 1Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 1Pancreatic Neoplasms 1Non-small Cell Lung Cancer Metastatic 1Neoplasms 1Neoplasm Metastasis 1Nasopharyngeal Carcinoma 1NSCLC 1Motor Activity 1Lung Neoplasms 1Locally Advanced Esophageal Squamous Cell Carcinoma 1Kidney Neoplasms 1Head and Neck Neoplasms 1Glioblastoma 1Esophageal Squamous Cell Carcinoma 1Endometrial Neoplasms 1

Interventions

avelumab 7Nivolumab 5pembrolizumab 4Specimen Handling 3Ipilimumab 3Biopsy 3cemiplimab 2atezolizumab 2Radiotherapy 2Magnetic Resonance Spectroscopy 2tocilizumab 1talimogene laherparepvec 1prednylidene 1poly ICLC 1lutetium Lu 177 dotatate 1lenvatinib 1fludarabine phosphate 1fludarabine 1flt3 ligand protein 1durvalumab 1deltacortene 1Tacrolimus 1Saline Solution 1Radiosurgery 1Radiation 1Prednisone 1MAPRE1 protein, human 1Lutetium-177 1Immunoglobulin G 1Immune Checkpoint Inhibitors 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Active not recruiting × Carcinoma, Merkel Cell × Immune Checkpoint Inhibitors × Clear all
NCT05358938 2026-02-06

Exercise to Boost Response to Checkpoint Blockade Immunotherapy

H. Lee Moffitt Cancer Center and Research Institute

Phase EARLY_PHASE1 Active not recruiting
22 enrolled
Dermatologic

Melanoma, Motor Activity, Skin Neoplasms, Carcinoma, Merkel Cell

Data powered by HemOnc (CC BY 4.0) Colophon âš¡